SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062056
Filing Date
2023-11-09
Accepted
2023-11-09 16:11:33
Documents
98
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q orgo-20230930.htm   iXBRL 10-Q 2622751
2 EX-31.1 orgo-ex31_1.htm EX-31.1 16669
3 EX-31.2 orgo-ex31_2.htm EX-31.2 17122
4 EX-32.1 orgo-ex32_1.htm EX-32.1 18110
  Complete submission text file 0000950170-23-062056.txt   10808943

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgo-20230930_pre.xml EX-101.PRE 440334
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT orgo-20230930_def.xml EX-101.DEF 279959
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgo-20230930.xsd EX-101.SCH 72057
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT orgo-20230930_cal.xml EX-101.CAL 64882
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgo-20230930_lab.xml EX-101.LAB 526554
92 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20230930_htm.xml XML 2148195
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 231392518
SIC: 2834 Pharmaceutical Preparations